【用戶】恩恩
【年級】國二上
【評論內容】https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851785/ConclusionsCVT-MDI significantly improved acute bronchodilation over ALB-HFA alone after 4 weeks of “as-needed” use for symptom relief, with a similar safety profile. This suggests additive bronchodilator effects of β2-agonist and anticholinergic treatment in moderate-to-severe, symptomatic asthma.
【用戶】【站僕】摩檸Morning
【年級】國三上
【評論內容】原本題目:10 下列何項藥品最適合用於急性氣喘發作的緩解?(A)Spiriva ® Handihaler (B)Combivent ® UDV(C)Symbicort ® Turbuhaler(D)Berotec ® MDI.修改成為10 下列何項藥品最適合用於急性氣喘發作的緩解?(A)Spiriva ® Handihaler (B)Combivent ® UDV(C)Symbicort ® Turbuhaler(D)Berotec ® MDI.